IBDEI0XC ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14847,0)
 ;;=K70.10^^85^836^11
 ;;^UTILITY(U,$J,358.3,14847,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14847,1,3,0)
 ;;=3^Alcoholic hepatitis (Acute) w/o Ascites
 ;;^UTILITY(U,$J,358.3,14847,1,4,0)
 ;;=4^K70.10
 ;;^UTILITY(U,$J,358.3,14847,2)
 ;;=^5008785
 ;;^UTILITY(U,$J,358.3,14848,0)
 ;;=K70.11^^85^836^10
 ;;^UTILITY(U,$J,358.3,14848,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14848,1,3,0)
 ;;=3^Alcoholic hepatitis (Acute) w/ Ascites
 ;;^UTILITY(U,$J,358.3,14848,1,4,0)
 ;;=4^K70.11
 ;;^UTILITY(U,$J,358.3,14848,2)
 ;;=^5008786
 ;;^UTILITY(U,$J,358.3,14849,0)
 ;;=K70.30^^85^836^7
 ;;^UTILITY(U,$J,358.3,14849,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14849,1,3,0)
 ;;=3^Alcoholic cirrhosis w/o Ascites
 ;;^UTILITY(U,$J,358.3,14849,1,4,0)
 ;;=4^K70.30
 ;;^UTILITY(U,$J,358.3,14849,2)
 ;;=^5008788
 ;;^UTILITY(U,$J,358.3,14850,0)
 ;;=K70.31^^85^836^6
 ;;^UTILITY(U,$J,358.3,14850,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14850,1,3,0)
 ;;=3^Alcoholic cirrhosis w/ Ascites
 ;;^UTILITY(U,$J,358.3,14850,1,4,0)
 ;;=4^K70.31
 ;;^UTILITY(U,$J,358.3,14850,2)
 ;;=^5008789
 ;;^UTILITY(U,$J,358.3,14851,0)
 ;;=K70.9^^85^836^12
 ;;^UTILITY(U,$J,358.3,14851,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14851,1,3,0)
 ;;=3^Alcoholic liver disease,unspecified
 ;;^UTILITY(U,$J,358.3,14851,1,4,0)
 ;;=4^K70.9
 ;;^UTILITY(U,$J,358.3,14851,2)
 ;;=^5008792
 ;;^UTILITY(U,$J,358.3,14852,0)
 ;;=C22.7^^85^836^72
 ;;^UTILITY(U,$J,358.3,14852,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14852,1,3,0)
 ;;=3^Malignant Neop Liver,Primary,Non-HCC
 ;;^UTILITY(U,$J,358.3,14852,1,4,0)
 ;;=4^C22.7
 ;;^UTILITY(U,$J,358.3,14852,2)
 ;;=^5000938
 ;;^UTILITY(U,$J,358.3,14853,0)
 ;;=C78.7^^85^836^74
 ;;^UTILITY(U,$J,358.3,14853,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14853,1,3,0)
 ;;=3^Malignant Neop Liver,Secondary (Metastases)
 ;;^UTILITY(U,$J,358.3,14853,1,4,0)
 ;;=4^C78.7
 ;;^UTILITY(U,$J,358.3,14853,2)
 ;;=^5001339
 ;;^UTILITY(U,$J,358.3,14854,0)
 ;;=B17.11^^85^836^53
 ;;^UTILITY(U,$J,358.3,14854,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14854,1,3,0)
 ;;=3^Hepatitis C,Acute w/ Coma
 ;;^UTILITY(U,$J,358.3,14854,1,4,0)
 ;;=4^B17.11
 ;;^UTILITY(U,$J,358.3,14854,2)
 ;;=^331777
 ;;^UTILITY(U,$J,358.3,14855,0)
 ;;=B17.10^^85^836^54
 ;;^UTILITY(U,$J,358.3,14855,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14855,1,3,0)
 ;;=3^Hepatitis C,Acute w/o Coma
 ;;^UTILITY(U,$J,358.3,14855,1,4,0)
 ;;=4^B17.10
 ;;^UTILITY(U,$J,358.3,14855,2)
 ;;=^5000542
 ;;^UTILITY(U,$J,358.3,14856,0)
 ;;=K74.0^^85^836^42
 ;;^UTILITY(U,$J,358.3,14856,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14856,1,3,0)
 ;;=3^Hepatic fibrosis
 ;;^UTILITY(U,$J,358.3,14856,1,4,0)
 ;;=4^K74.0
 ;;^UTILITY(U,$J,358.3,14856,2)
 ;;=^5008816
 ;;^UTILITY(U,$J,358.3,14857,0)
 ;;=B18.0^^85^836^50
 ;;^UTILITY(U,$J,358.3,14857,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14857,1,3,0)
 ;;=3^Hepatitis B,Chronic w/ Delta
 ;;^UTILITY(U,$J,358.3,14857,1,4,0)
 ;;=4^B18.0
 ;;^UTILITY(U,$J,358.3,14857,2)
 ;;=^5000546
 ;;^UTILITY(U,$J,358.3,14858,0)
 ;;=K75.4^^85^836^16
 ;;^UTILITY(U,$J,358.3,14858,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14858,1,3,0)
 ;;=3^Autoimmune Hepatitis
 ;;^UTILITY(U,$J,358.3,14858,1,4,0)
 ;;=4^K75.4
 ;;^UTILITY(U,$J,358.3,14858,2)
 ;;=^336610
 ;;^UTILITY(U,$J,358.3,14859,0)
 ;;=R93.2^^85^836^1
 ;;^UTILITY(U,$J,358.3,14859,1,0)
 ;;=^358.31IA^4^2
